|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.75 GBX | 0.00% |
|
0.00% | -8.51% |
| 12-01 | IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025 | CI |
| 11-17 | Ixico wins GBP3.7 million deal to support Huntington's Disease trial | AN |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 7.73M | -34.7% | -37.36% | -19.15% | - | 1.05x | ||
| 7.25B | 9.67% | 17.9% | 6.77% | 3.48% | 1.5x | ||
| 15.4B | 8.91% | 20.12% | 33.53% | 5.12% | 3.33x | ||
| 3.81B | -16.92% | -14.91% | -17.71% | -11.1% | 4.46x | ||
| 2.41B | 11.88% | 13.83% | 2.46% | 2.14% | 1.28x | ||
| 2.11B | 19.17% | 21.38% | 58.42% | 21.52% | -1.39x | ||
| 8.28B | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | ||
| 705M | -64.4% | -67.38% | -93.12% | -15.15% | 2.26x | ||
| 693M | -107.63% | -20.47% | - | -25.37% | 0.13x | ||
| 376M | -103.97% | -76.66% | - | -37.71% | -1.14x | ||
| 7.2B | 5.84% | 14.63% | 7.8% | 3.73% | 1.93x | ||
| 1.98B | 4.23% | 28.66% | 13.31% | 8.32% | 0.34x | ||
| 1.22B | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | ||
| 12.94M | -1,409.6% | -1,383.2% | -148.95% | - | 0.4x | ||
| 4.05B | 0.25% | 19.9% | 15.1% | 6.78% | 2.05x | ||
| 509M | -13.19% | -41.67% | -31.26% | -21.6% | -0.14x | ||
| 1.68B | 14.61% | 17.14% | 13.7% | 7.12% | 1.33x | ||
| Average | 3.39B | -97.66% | -84.55% | -8.76% | -2.28% | 1.15x | |
| Weighted average by Cap. | 5.25B | -50.42% | -38.61% | 0.02% | -1.32% | 1.69x |
- Stock Market
- Equities
- IXI Stock
- Sector IXICO plc
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















